The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
Get on board before the train leaves the platform :)
Gl all
As I said earlier. Great times ahead in the next week and weeks.
I took my opportunity first thing to top up. Buy and Hold for strong news that is on the way. But not just one off news, a stream of good news is on the way over the next few weeks and months
Just to give that post below more context....the context is that selling out part of my shares too early has always meant I had to buy in at a higher price except when I have been lucky to top up on dips...
So if I had left everything in Avacta...I be a lot more profitable than my profits show
Gl all
The only time I have lost money over the last 2 months running on Avacta is when I have sold shares.
The only time I have made money on Avacta in the last 2 months running is when I have bought shares.
So today I made the smartest decision this morning and I bought shares :)
Gl all
Hello all,
I took my opportunity to top up.
We have a great few weeks /months and more coming with the key news to come shortly I hope.
With our latest collaboration this made sure we are now firmly in the media's eye and people will be taking notice of Avacta in respect of its rapid Antigen saliva based test. It is Affordable, Rapid, Mass production focus and is Easy to Administer with home testing capability. The final ingredient to this ground breaking combination is accuracy. This could test alone can take Avacta to the next level. The steps taken so far below tell us this is going to be a very accurate test:
- Courting the media early on including Sky
- Signing up with Cyiva
- Deal with Medusa
The next few weeks and months not just on Antigen testing but for our other existing work (taking place) could be a game changer for the countries around the world in this global crisis and for Avacta too.
Lots of news of other fronts to come too. Remember you were told by Avacta management very early on that they were working hard to commercialise the rapid testing and now you are seeing it come to fruition.
I wouldn't say I was foolish just a bit enthusiastic.
Foolish would have been holding on in to this dip lol
I got out pretty quickly so my hit was limited (10% loss), then traded the swings since
Still have a small interest in this which would clear the loss if this thing picks up a bit
Here you are newby:
Price Monitoring Extensions
For anyone trading in smaller cap companies, price monitoring extensions can be an extremely common occurrence. But what are they? Why do they occur? And are they good or bad? Find out the answers to these questions and more with this article on price monitoring extensions.
What is the role of an auction?
Any discussion on price monitoring extensions must firstly begin by covering auctions. Auctions are small intervals during the regular trading day where the electronic order book is effectively frozen. During this time, orders are collected from the market – known as the Call Period – and the matching algorithm considers the orders that have been entered and calculates the price that the maximum amount of shares can be executed. The intention is to find the most popular and reliable price for a security.
At the end of this Call Period, orders that can be matched are executed in an event referred to as the uncrossing, which takes place within a randomised 30 seconds of the end of the Call Period. However, should the auction fail to generate a reliable price, then a price monitoring extension is generated.
What happens during a price monitoring extension?
Should the preceding auction fail to generate a price within a predetermined percentage above or below the reference price, which is the price just before the stock went into the auction, then a price monitoring extension RNS is automatically released to the market, and the Call Period is extended by another 5 minutes. This extra 5 minutes provides participants the chance to review the prices of the orders that have been entered and if appropriate add, delete or amend.
Should this additional period still fail to generate a reliable price, then a second price monitoring extension is released to the market, and the Call Period is extended by another 5 minutes. On this occasion, should the additional period also fail to generate a price within tolerance levels, then this price will be taken forward and the orders that can be matched will be executed in the uncrossing.
Why might the auction fail to generate an acceptable price?
One reason might be that the share has such a wide spread during that day of trading that the bid and ask price are far away from the mid-price. Given that the majority of AIM companies trade on the SETSqx trading system, where there is no maximum spread requirements, this will likely be the problem in a lot of instances.
Another reason for a price monitoring extenion could be the release of news that has a sudden and significant impact on the price that investors are willing to pay for the company’s shares.
https://aim-watch.com/project/price-monitoring-extensions-explained/
Lol flying machine
Yes he does seem to call the RNS right lately not sure how....
even though I got stung by this stock before
I kept a small holding as I do agree it has potential
but it better get moving soon with an update as there is competition all around
Any chance of this cat doing a bounce?
Seems to be taking its time
I think you posted this on the wrong board
As well as following the science we need to follow the end users too, i.e. Care Homes!
Radio 4 interview today on a care home owner who has said even if he needed to test weekly he would need 10,000 kits for his staff and residents. So the market is massive.
He was asked would he use home kits going forward as he had previously been given government provided swab tests. He cut into the interviewer and said he would use them again BUT SWAB tests were very invasive for his residents. He would much prefer Saliva based tests as they are less intrusive for his residents who suffer dementia.
Easy of administering tests....AVACTA wins every time....follow the science and end user feedback
Gl all
I have drunk too much wine this afternoon to write anything sensible haha
But am sure our more knowledgeable posters will pitch in this evening
.....then what the f*ck are we going to do if this share hits £5 LOL
Excuse my French but it is an exciting share to be in.
And at a time where most of us have been depressed some days by the weight of lockdown...then it is nice to be involved in something that could bring some light at the end of the tunnel
Gl all!
I know the signs as I had to do that at least once today already and it cost me money!
Gl all
-constant feelings of being on edge
-checking the share price to see what it does next
-calculating how much it will be to get back in and how much it cost you to sell early
-the nagging feeling you sold too early
-thinking which other stock you can put your money and then wondering why you sold
-logging into your share dealing account, finding Avacta and then pressing buy
Then feeling more relaxed that you have not missed the boat....:)
since there are numerous possibilities on what the leak could relate to.....maybe we should run a sweepstake:)
1. Cytiva / Avacta testing strips success update
2. Major partner on therapy or vaccine
3. Dual listing
4. Takeover bid
5. Left centre news that is not on peoples radar
Ok thanks all
Yes I would happily take a finish of 180p tbh but if it makes 190p then it is all gravy
Any dips and I am sure people will look for an entry or re-entry point as this share is looking very strong
Hello all,
Seems to be bouncing between 178p and 188p at the moment.
Does one of our fellow technical posters have the latest resistance points 'without news'?
Gl all
I agree Janiax re SP comparisons.
Hopefully if Avacta's plans come to fruition we will be compared to a lot bigger companies later down the line too!